MD Pascal J Goldschmidt, - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of MD Pascal J Goldschmidt,. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate MD Pascal J Goldschmidt, has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by MD Pascal J Goldschmidt,. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MD / Pediatrix Medical Group, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MD / Pediatrix Medical Group, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2016-12-07	MD	Goldschmidt, MD Pascal J	2,100	66.5150	2,100	66.5150	139,682	86	72.0300	11,582	8.29

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales MD / Pediatrix Medical Group, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MD / Pediatrix Medical Group, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2019-03-13	MD	Goldschmidt, MD Pascal J	3,300	30.4033	3,300	30.4033	100,331	365	12.1300	-60,301	-60.10
2017-06-14	MD	Goldschmidt, MD Pascal J	1,969	57.5700	1,969	57.5700	113,355
2017-02-10	MD	Goldschmidt, MD Pascal J	25,294	67.8152	25,294	67.8152	1,715,318
2016-09-14	MD	Goldschmidt, MD Pascal J	475	65.0000	475	65.0000	30,875
2016-09-14	MD	Goldschmidt, MD Pascal J	566	65.0100	566	65.0100	36,796
2016-09-14	MD	Goldschmidt, MD Pascal J	303	65.0200	303	65.0200	19,701
2016-09-14	MD	Goldschmidt, MD Pascal J	156	65.0300	156	65.0300	10,145
2016-03-11	MD	Goldschmidt, MD Pascal J	3,100	65.0000	3,100	65.0000	201,500
2015-12-11	MD	Goldschmidt, MD Pascal J	5,250	70.9864	5,250	70.9864	372,679
2015-07-31	MD	Goldschmidt, MD Pascal J	1,500	82.3559	1,500	82.3559	123,534
2015-03-09	MD	Goldschmidt, MD Pascal J	8,500	71.2539	8,500	71.2539	605,658
2014-05-09	MD	Goldschmidt, MD Pascal J	30,000	57.1100	30,000	57.1100	1,713,300
2012-09-11	MD	Goldschmidt, MD Pascal J	8,792	72.5875	8,792	72.5875	638,189

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases OPK / OPKO Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MD / Pediatrix Medical Group, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales OPK / OPKO Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MD / Pediatrix Medical Group, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by MD Pascal J Goldschmidt, as disclosed to the Securities Exchange Commission (SEC).